Women with vaginal discomfort Is the risk of depression or self-harm greater in women who have experienced complications following transvaginal mesh midurethral sling placement? Women with ...

October 21, 2008 — Clinicians should receive specialized training for the transvaginal placement of mesh products and be vigilant for adverse events, the US Food and Drug Administration (FDA) warned ...

Add Yahoo as a preferred source to see more of our stories on Google. Surgical mesh implants used to treat women's pelvic organ problems are being removed from the Canadian market following a safety ...

WASHINGTON (CN) - As reports of serious complications continue to rise, the Food and Drug Administration has issued two orders to manufacturers to strengthen requirements for transvaginal surgical ...

A TURBT allows examination beyond the bladder. Women younger than 46 years undergoing surgical correction are especially at risk for depression. Women with transvaginal mesh complications requiring ...

Manufacturers of surgical mesh products must stop selling and distributing their products in the United States immediately, the US Food and Drug Administration ordered Tuesday. The FDA said it "has ...

(Reuters) - A Delaware jury on Thursday ordered Boston Scientific to pay $100 million to a woman who said she was injured by transvaginal mesh, a device that is the subject of more than 25,000 ...

(Reuters) - A Michigan medical funder was ordered to pay about $1.3 million on Monday for his role in a scheme to convince women to have unnecessary surgery to remove their transvaginal mesh implants ...

Microscopic particles left behind by vaginal mesh could continue to trigger the immune system to attack healthy tissue even after the material has been removed, according to researchers. Experts ...

The U.S. Food and Drug Administration has issued an update on serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse (POP), indicating these ...

In its third-quarter earnings call last October, Boston Scientific's chief financial officer said that the company upped its legal reserves to $945 million, a $139 million increase from the second ...